Orchard Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	262.04	230.49	61.03	-88.13	-175.69
Depreciation & Amortization	89	65.68	-6.82	103.77	121.36
Loss (Gain) From Sale of Assets	-2.66	-7.71	-5.04	-15.48	1.68
Asset Writedown & Restructuring Costs	-52.54	-46.78	-	-65.22	7.5
Other Operating Activities	9.23	9	157.79	213.58	129.78
Change in Accounts Receivable	61.89	26.56	19.21	-39.55	-15.45
Change in Other Net Operating Assets	-54.55	-1.55	-0.85	-0.5	0.82
Operating Cash Flow	312.41	275.69	249.7	108.46	70.01
Operating Cash Flow Growth	188.03%	10.41%	130.21%	54.94%	-
Capital Expenditures	-93.81	-60.03	-64.5	-46.45	-27.09
Sale of Property, Plant & Equipment	10.76	20.22	605.84	42.46	21.88
Investment in Securities	-1.88	-0.75	-	-	-
Other Investing Activities	39.21	35.11	0.51	0.36	4.36
Investing Cash Flow	-45.71	-5.45	541.85	-3.63	-0.86
Long-Term Debt Issued	-	839.38	-	-	-
Long-Term Debt Repaid	-	-1,220	-727.86	-29.71	-19.87
Net Debt Issued (Repaid)	-153.96	-380.5	-727.86	-29.71	-19.87
Issuance of Common Stock	8.03	262.53	1.93	-	-
Common Dividends Paid	-80.62	-20.48	-14.79	-	-
Other Financing Activities	-60.96	-73.43	-107.32	-83.85	-45.23
Financing Cash Flow	-287.51	-211.88	-848.05	-113.56	-65.1
Foreign Exchange Rate Adjustments	0.92	-2.8	4.5	-9.52	0.13
Miscellaneous Cash Flow Adjustments	-3.1	-2.76	-5.08	-153.76	-170.1
Net Cash Flow	-23	52.8	-57.08	-172.01	-165.91
Free Cash Flow	218.59	215.66	185.19	62.02	42.91
Free Cash Flow Growth	252.47%	16.45%	198.61%	44.52%	-
Free Cash Flow Margin	40.42%	47.52%	38.05%	13.03%	10.62%
Free Cash Flow Per Share	0.47	0.51	1.46	0.49	-
Cash Interest Paid	72.67	73.43	107.32	83.85	45.23
Levered Free Cash Flow	-	113.82	-43.94	-9.19	-
Unlevered Free Cash Flow	-	170.72	31.83	57.83	-
Change in Net Working Capital	-	-47.49	-4.09	32.93	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.